BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9088037)

  • 1. Amplification of the c-erbB-2 gene detected by FISH in gastric cancers.
    Sato T; Abe K; Kurose A; Uesugi N; Todoroki T; Sasaki K
    Pathol Int; 1997; 47(2-3):179-82. PubMed ID: 9088037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.
    Takehana T; Kunitomo K; Kono K; Kitahara F; Iizuka H; Matsumoto Y; Fujino MA; Ooi A
    Int J Cancer; 2002 Apr; 98(6):833-7. PubMed ID: 11948459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization.
    Ooi A; Kobayashi M; Mai M; Nakanishi I
    Lab Invest; 1998 Mar; 78(3):345-51. PubMed ID: 9520947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization.
    Ishikawa T; Kobayashi M; Mai M; Suzuki T; Ooi A
    Am J Pathol; 1997 Sep; 151(3):761-8. PubMed ID: 9284825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2 expression in primary gastric carcinomas and their metastases.
    David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M
    Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
    Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
    Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amplification of HER2 gene in gastric carcinoma detected by dual in-situ hybridization].
    Sin LF; Vong HT; Wen JM; Yip YC
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):168-71. PubMed ID: 22800479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
    Kobayashi M; Ooi A; Oda Y; Nakanishi I
    Hum Pathol; 2002 Jan; 33(1):21-8. PubMed ID: 11823970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.
    Kanta SY; Yamane T; Dobashi Y; Mitsui F; Kono K; Ooi A
    Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer.
    Tsujimoto H; Sugihara H; Hagiwara A; Hattori T
    Virchows Arch; 1997 Dec; 431(6):383-9. PubMed ID: 9428926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
    Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
    Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
    Yao JG; Wang CH; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):245-248. PubMed ID: 28376590
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor in gastric carcinomas.
    Takehana T; Kunitomo K; Suzuki S; Kono K; Fujii H; Matsumoto Y; Ooi A
    Clin Gastroenterol Hepatol; 2003 Nov; 1(6):438-45. PubMed ID: 15017643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas.
    Oda N; Tsujino T; Tsuda T; Yoshida K; Nakayama H; Yasui W; Tahara E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):273-7. PubMed ID: 1970690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
    Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
    Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach.
    Yonemura Y; Ninomiya I; Tsugawa K; Fushida S; Fujimura T; Miyazaki I; Uchibayashi T; Endou Y; Sasaki T
    Cancer Detect Prev; 1998; 22(2):139-46. PubMed ID: 9544434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma.
    Ross JS; Sheehan CE; Hayner-Buchan AM; Ambros RA; Kallakury BV; Kaufman RP; Fisher HA; Rifkin MD; Muraca PJ
    Cancer; 1997 Jun; 79(11):2162-70. PubMed ID: 9179063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of EGFR and ERBB2 (HER2) in Gastric and Gastroesophageal Carcinomas: EGFR Amplification is Associated With a Worse Prognosis in Early Stage and Well to Moderately Differentiated Carcinoma.
    Liao JB; Lee HP; Fu HT; Lee HS
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):374-382. PubMed ID: 27753660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.